학술논문

Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer
Document Type
Journal
Source
ONCOLOGY; 2005, 69 5, p372-p383, 12p.
Subject
Language
English
ISSN
00302414